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Background: We reutilized the existing Three-Prefecture Cohort to evaluate the relationship between
lifestyle factors and the incidence or mortality from non-communicable diseases.
Methods: This study was a prospective population-based observation conducted from the 1980s to 2000
in three prefectures (Miyagi, Aichi, and Osaka) in Japan. The study subjects were residents aged 40
years who received a questionnaire. The follow-up period was 15 years from the baseline survey in each
study area. A self-administered questionnaire, which included items on participants' demographic fac-
tors and lifestyle characteristics, was administered. Vital status and date of death were collected from
residence certificates by the local government, and cause of death was identified using vital statistics.
Cancer incidence and the date of diagnosis were collected from local cancer registry data.
Results: A total of 46,421 men and 54,189 women were eligible for our analysis. The person-years of
follow-up for cancer incidence were 464,664 and 567,271 for men and women, respectively, and those
for death were 527,940 and 648,601 for men and women, respectively. There were 8479 cancer in-
cidences (5106 men and 3373 women) and 20,240 total deaths (11,156 men and 9084 women). The
stomach was the most common cancer incidence site for both men (25.6%) and women (18.6%). The
leading cause of death was cancer among men (35.0%) and cardiovascular disease among women (41.0%).
Conclusions: The Three-Prefecture Cohort Study enabled us to reveal the association of multiphasic
lifestyle factors with cancer incidence and mortality. The study will also allow us to conduct a pooled
analysis in combination with other large-scale cohorts.
© 2016 The Authors. Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
A cohort study is one of the ways to evaluate the relationship
between lifestyle factors and the incidence or mortality from non-al Medicine and Population
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d/4.0/).communicable diseases. Although huge amounts of money and
long-term observation are needed to conduct a cohort study, such a
design could minimize selection bias and maximized external
validity. Large-scale prospective cohorts focused on healthy pop-
ulations (e.g., the Japan Collaborative Cohort [JACC] Study1 or the
Japan Public Health-Based Prospective Cohort [JPHC] Study2) have
been conducted since 1980s in Japan. There have also been large
cohort studies worldwide, such as the National Institutes of
HealtheAmerican Association of Retired Persons Diet and Healthn Epidemiological Association. This is an open access article under the CC BY-NC-ND
Table 1
Participants of the Three-Prefecture Cohort study.

















aged 40 years old
25,237 15,891 24,489 12,854 39,307 21,230 139,008
Delivered questionnaires 17,805 14,926 23,331 12,815 27,051 21,101 117,029
Responded questionnaires 17,195 14,574 21,535 12,003 20,665 18,565 104,537
Response rate (%)a (68.1) (91.7) (87.9) (93.4) (52.6) (87.4) (75.2)
Response rate (%)b (96.6) (97.6) (92.3) (93.7) (76.4) (88.0) (89.3)
a Denominator was subjects who were all residents aged 40 years old.
b Denominator was subjects who were delivered the self-administrated questionnaire.
J. Sado et al. / Journal of Epidemiology 27 (2017) 193e199194Study in the United States,3 the European Prospective Investigation
into Cancer and Nutrition in Europe,4 and the Korean Multi-center
Cancer Cohort Study in Korea.5 Indeed, many findings have been
obtained from these studies.
The Three-Prefecture Cohort Study was a prospective
population-based observational study launched in 1983, which
targeted approximately 100,000 inhabitants in Miyagi Prefecture,
Aichi Prefecture, and Osaka Prefecture in Japan and conducted a
questionnaire survey to reveal the association of multiphasic life-
style factors with cancer incidence or mortality. Here, we briefly
described the study concept and the cohort population's profile.
Materials and methods
Study design and settings
This cohort, which has been under prospective observation
since 1983, was studied to assess the long-term effects of air
pollution on mortality from lung cancer and respiratory diseases.6,7
The study areas were chosen because they contained a national air
monitoring station and had well-managed cancer surveillance
systems in 1983, including eight selected urban/rural areas in
Miyagi Prefecture (Sendai City and Wakuya/Tajiri Town), AichiTable 2
Distribution of cohort participants at baseline by gender, age, and region.
Age at baseline, years
40e44 45e49 50e54 55e59
Men
Japan census population 1985 (x1,000) 4494 4053 3898 3391
% 19.3 17.4 16.8 14.6
Three-prefecture cohort participants 8082 7735 7795 6804
% 17.4 16.7 16.8 14.7
Miyagi Prefecture (urban) 1137 1161 1194 1057
Miyagi Prefecture (rural) 903 1020 1213 1082
Aichi Prefecture (urban) 1841 1821 1760 1358
Aichi Prefecture (rural) 1095 989 963 823
Osaka Prefecture (urban) 990 1161 1265 1183
Osaka Prefecture (rural) 2116 1583 1400 1301
Women
Japan census population 1985 (x1,000) 4554 4140 3971 3574
% 17.1 15.6 15.0 13.5
Three-prefecture cohort participants 8522 8522 8337 7814
% 15.7 15.7 15.4 14.4
Miyagi Prefecture (urban) 1318 1447 1508 1379
Miyagi Prefecture (rural) 938 1161 1354 1268
Aichi Prefecture (urban) 1911 1944 1785 1621
Aichi Prefecture (rural) 1071 1050 897 869
Osaka Prefecture (urban) 1264 1380 1404 1377
Osaka Prefecture (rural) 2020 1540 1389 1300Prefecture (Nagoya City and Inuyama City), and Osaka Prefecture
(Osaka City and Nose/Kanan/Kumatori Town). Since the 1970s,
there has been a network of ambient air monitoring stations in
Japan operated by the Ministry of Environment (formerly the Na-
tional Environment Agency) and local governments. In this study,
we defined rural areas as cities/towns with general air pollution
monitoring stations (control area) and urban areas as cities/towns
with automobile exhaust gas measurement stations (pollution
area).6 Self-administered questionnaires in sealed envelopes were
distributed by hand to targeted individuals in cooperation with the
municipal government in each area and were collected after a set
period of time. The study committee, consisting of health center
directors, local officials, and residents' association representatives,
was established to protect personal information of the participants
and ensure the accuracy of the study. In this study, we merged
individuals' data with their cancer incidence information based on
personal name, gender, and date of birth. The proportion of death
certificate only (DCO) deaths in each areawas 9.1%e17.8% in Miyagi
Prefecture,8 28.1%e32.6% in Aichi Prefecture,9 and 20.7%e23.4% in
Osaka Prefecture.10
The study subjects were residents aged 40 years who received
a questionnaire, and they were enrolled between 1983 and 1985.
The investigation was begun in Osaka Prefecture in 1983, in MiyagiTotal %
60e64 65e69 70e74 75e79 80e84 85
2349 1771 1486 997 546 247 23,232
10.1 7.6 6.4 4.3 2.4 1.1 100.0
5018 4067 3410 2153 973 384 46,421
10.8 8.8 7.3 4.6 2.1 0.8 100.0
859 765 586 371 189 72 7391 15.9
784 607 490 333 116 53 6601 14.2
1035 818 675 442 220 74 10,044 21.6
561 476 377 250 109 49 5692 12.3
927 764 718 440 193 67 7708 16.6
852 637 564 317 146 69 8985 19.4
3011 2394 2046 1438 906 525 26,559
11.3 9.0 7.7 5.4 3.4 2.0 100.0
6604 5196 4261 2722 1471 740 54,189
12.2 9.6 7.9 5.0 2.7 1.4 100.0
1234 937 740 453 257 110 9383 17.3
1009 758 717 391 220 154 7970 14.7
1361 1020 843 578 264 141 11,468 21.2
711 638 459 346 171 94 6306 11.6
1246 1031 820 501 291 125 9439 17.4
1043 812 682 453 268 116 9623 17.8
Table 3
Selected baseline demographic and lifestyle characteristics of participants by
gender.
Men Women
(n ¼ 46,421) (n ¼ 54,189)
Mean age, years (standard deviation) 56.1 (11.2) 57.1 (11.6)
Regions, n (%)
Miyagi, urban 7391 (15.9) 9383 (17.3)
Miyagi, rural 6601 (14.2) 7970 (14.7)
Aichi, urban 10,044 (21.6) 11,468 (21.2)
Aichi, rural 5692 (12.3) 6306 (11.6)
Osaka, urban 7708 (16.6) 9439 (17.4)
Osaka, rural 8985 (19.4) 9623 (17.8)
Health insurance type, n (%)
National health insurance 20,877 (45.0) 25,263 (46.6)
Government/union-managed health insurance 19,267 (41.5) 20,864 (38.5)
Mutual aid associations health insurance 3897 (8.4) 4250 (7.8)
Others 577 (1.2) 891 (1.6)
Missing 1803 (3.9) 2921 (5.4)
History of hypertension, n (%)
Current 8289 (17.9) 10,138 (18.7)
Past 1709 (3.7) 2189 (4.0)
Never 19,820 (42.7) 23,811 (43.9)
Missing 16,603 (35.8) 18,051 (33.3)
History of diabetes, n (%)
Current 2725 (5.9) 1803 (3.3)
Past 738 (1.6) 275 (0.5)
Never 20,895 (45.0) 25,586 (47.2)
Missing 22,063 (47.5) 26,525 (48.9)
Body mass index, n (%)
19.0 kg/m2 4310 (9.3) 6255 (11.5)
19.0e21.9 kg/m2 14,995 (32.3) 17,153 (31.7)
22.0e24.9 kg/m2 17,155 (37.0) 17,294 (31.9)
25.0e29.9 kg/m2 7528 (16.2) 9378 (17.3)
30.0 kg/m2 515 (1.1) 1130 (2.1)
Missing 1918 (4.1) 2979 (5.5)
Alcohol drinking, n (%)
Never 7122 (15.3) 26,119 (48.2)
Former 2787 (6.0) 1094 (2.0)
Current occasional 11,884 (25.6) 13,497 (24.9)
Current almost daily 21,776 (46.9) 2942 (5.4)
Missing 2852 (6.1) 10,537 (19.4)
Smoking status, n (%)
Never 7411 (16.0) 37,281 (68.8)
Former 10,805 (23.3) 1746 (3.2)
Current 23,969 (51.6) 5199 (9.6)
Missing 4236 (9.1) 9963 (18.4)
Green and yellow vegetable consumption, n (%)
1e2 times/month 3311 (7.1) 2183 (4.0)
1e2 times/week 10,320 (22.2) 8563 (15.8)
3e4 times/week 12,623 (27.2) 14,918 (27.5)
Almost daily 17,509 (37.7) 24,445 (45.1)
Missing 2658 (5.7) 4080 (7.5)
Non-green and non-yellow vegetable consumption, n (%)
1e2 times/month 1491 (3.2) 1111 (2.1)
1e2 times/week 6634 (14.3) 5229 (9.6)
3e4 times/week 12,267 (26.4) 12,816 (23.7)
Almost daily 23,782 (51.2) 31,276 (57.7)
Missing 2247 (4.8) 3757 (6.9)
Fruit consumption, n (%)
1e2 times/month 5040 (10.9) 2452 (4.5)
1e2 times/week 9631 (20.7) 6291 (11.6)
3e4 times/week 10,303 (22.2) 10,649 (19.7)
Almost daily 18,308 (39.4) 30,535 (56.3)
Missing 3139 (6.8) 4262 (7.9)
Miso soup consumption, n (%)
1e2 times/month 3141 (6.8) 3823 (7.1)
1e2 times/week 7127 (15.4) 8473 (15.6)
3e4 times/week 8035 (17.3) 9746 (18.0)
Almost daily 25,913 (55.8) 28,213 (52.1)
Missing 2205 (4.8) 3934 (7.3)
Pickled vegetable consumption, n (%)
Scarcely any 2296 (4.9) 2095 (3.9)
1e2 times/month 2311 (5.0) 2380 (4.4)
1e2 times/week 5114 (11.0) 5340 (9.9)
3e4 times/week 6508 (14.0) 6753 (12.5)
Almost daily 27,016 (58.2) 32,802 (60.5)
Table 3 (continued )
Men Women
(n ¼ 46,421) (n ¼ 54,189)
Missing 3176 (6.8) 4819 (8.9)
Type of job, n (%)
Professional technical and civil workers 3835 (8.3) 2805 (5.2)
Managerial workers 959 (2.1) 98 (0.2)
Clerical workers 5415 (11.7) 5197 (9.6)
Sales workers 5495 (11.8) 3663 (6.8)
Agricultural, forestry and fisheries workers 2844 (6.1) 3127 (5.8)
Construction workers 92 (0.2) 9 (0.0)
Workers in transport and communications 1814 (3.9) 309 (0.6)
Craftsman, production
process worker, and laborers
9537 (20.5) 4740 (8.7)
Workers in security 567 (1.2) 18 (0.0)
Service workers 1069 (2.3) 2750 (5.1)
Unemployed 1284 (2.8) 10,666 (19.7)
Missing 13,510 (29.1) 20,807 (38.4)
J. Sado et al. / Journal of Epidemiology 27 (2017) 193e199 195Prefecture in 1984, and in Aichi Prefecture in 1985. The number of
questionnaire responders was 17,195/17,805 (96.6%) in Sendai City,
14,574/14,926 (97.6%) inWakuya/Tajiri Town, 21,535/23,331 (92.3%)
in Nagoya City, 12,003/12,815 (93.7%) in Inuyama City, 20,665/
27,051 (76.4%) in Osaka City, and 18565/21,101 (88.0%) in Nose/
Kanan/Kumatori Town (Table 1). Of 104,537 responders, a total of
100,629 were included as subjects, after excluding those who
answered a questionnaire in duplicate or did not provide their
name/gender/date of birth because investigators could not follow
up the outcome data in the Three-Prefecture Cohort study.
Questionnaire
Baseline questionnaire items included the following: area of
residence, gender, height, weight, health condition at that time,
past medical history, type of insurance, health check-up/cancer
screening history, frequency of food intake, smoking, alcohol
drinking status, parent's medical history, smoking status of co-
habitants, house environment, occupation (such as the longest
period of employment), and reproductive history (only for women).
Medical history included: past history of diabetes mellitus, hyper-
tension, stroke, and emphysema; and stomach cancer screening by
x-ray examination, blood pressuremeasurement, and uterus cancer
screening (only for women). Food intake frequency of items, such
as rice, bread, meat, fish, eggs, milk, green/yellow vegetables, non-
green/yellow vegetables, fruit, miso soup, and pickled vegetables,
as well as drinking beverages, such as green tea, black tea, and
coffee, was assessed categorically.
Follow-up
The follow-up period was defined as 15 years from the baseline
survey in each study area, except for cancer incidence data in
Miyagi Prefecture, for which follow-up was 9 years. The cohorts
were followed from 1984 to 1999 inMiyagi Prefecture, from 1985 to
2000 in Aichi Prefecture, and from 1983 to 2000 in Osaka Prefec-
ture. Vital status, date of death, and date of move-out from the
study areawere confirmed by the local government using residence
certificates. Cause of death was identified using death certificate.
Cancer incidence and the date of diagnosis were collected from
local cancer registry data.
Statistical analysis
The definition of disease was determined based on the Inter-
national Classification of Diseases 9th version (ICD-9) for data
J. Sado et al. / Journal of Epidemiology 27 (2017) 193e199196collected from 1983 to 1994 and or the 10th version (ICD-10) for
data collected from 1995 to 2000 in this study. We counted the
number of incident cancers and deaths of all cancer and cancer of
individual sites, and also the number of deaths according to cause
of death. When mortality rates were calculated, person-years of
follow-up for mortality were counted from the date of the baseline
survey to the date of death, date of move-out from the study area,
or the end of 15-year follow-up (whichever occurred first). For
cancer incidence rates, date of diagnosis of first primary cancer was
added to the above list. In addition, standardized incidence ratios
(SIRs) and standardized mortality ratios (SMRs) of all-cause and all
cancer were calculated using age-adjusted mortality/incidence
rate, which was calculated using 5-year age-specific rates in each
year according to the cancer registry and vital statistics in Japan.11,12
Statistical analyses were implemented using STATA version 13 MP
(Stata Corp., College Station, TX, USA).Ethics
The study was approved by the institutional review board of the
National Cancer Center and the Ethics Committee of Osaka Uni-
versity School of Medicine. We received permission from the
municipal governments to survey residents. The response to the
questionnaire by participant was considered consent to participate
in the survey. Tohoku University, Aichi Cancer Center, and Osaka
Medical Center for Cancer and Cardiovascular Diseases were pri-
marily responsible for analyzing information on baseline surveys,
linking with cancer incidence and cause of death data, and altering
the data set to unlinkable anonymized data. Although the National
Cancer Center had originally managed the integrated datasets,
Osaka University manages them at present. In the Three-PrefectureTable 4
15-year follow-up status until 2000 by gender and age.
Age at baseline, years
40e44 45e49 50e
Men
Number at baseline 8082 7735 779
Number of all cancer incidences 215 371 665
% (Number of all cancer incidences/Number at baseline) 2.7 4.8 8.5
Number of deaths 320 506 960
% (Number of all cause deaths/Number at baseline) 4.0 6.5 12.3
Number of all cancer deaths 135 230 463
% (Number of all cancer deaths/Number at baseline) 1.7 3.0 5.9
Number who left study area 2359 1991 160
% (Number who left study area/Number at baseline) 29.2 25.7 20.6
Person-years (incidence) 87,758 83,560 83,3
Incidence rate (all cancer per 1000 person-years) 2.4 4.4 8.0
Person-years (mortality) 96,389 93,649 95,4
Mortality rate (all cause per 1000 person-years) 3.3 5.4 10.1
Mortality rate (all cancer per 1000 person-years) 1.4 2.5 4.9
Women
Number at baseline 8522 8522 833
Number of cancer incidences 229 291 386
% (Number of all cancer incidences/Number at baseline) 2.7 3.4 4.6
Number of deaths 181 301 446
% (Number of all cause deaths/Number at baseline) 2.1 3.5 5.3
Number of all cancer deaths 98 170 211
% (Number of all cancer deaths/Number at baseline) 1.1 2.0 2.5
Number who left study area 2242 2051 169
% (Number who left study area/Number at baseline) 26.3 24.1 20.3
Person-years (incidence) 94,984 94,636 92,1
Incidence rate (all cancer per 1000 person-years) 2.4 3.1 4.2
Person-years (mortality) 105,776 107,461 107
Mortality rate (all cause per 1000 person-years) 1.7 2.8 4.2
Mortality rate (all cancer per 1000 person-years) 0.9 1.6 2.0Cohort study, researchers only analyzed unlinkable anonymous
data.Results
Of 100,629 participants aged 40e99 years old at baseline, 19
(0.02%) were excluded because their responses preceded the date
of beginning of follow-up, which was unified in each area after
various dates of individual response to the questionnaire. As a
result, 46,421 men and 54,189 women were eligible for this study.
Details of the distribution of cohort participants at baseline by sex,
age, and region are noted in Table 2. The person-years of follow-up
for cancer incidence were 464,664 and 567,271 for men and
women, respectively, and the person-years for death were 527,940
and 648,601 for men and women, respectively.
Table 3 shows selected baseline characteristics of participants by
sex. Mean age among men and women was 56.1 and 57.1 years,
respectively, and the proportion of participants with a body mass
index of 22.0e24.9 kg/m2 was 37.0% among men and 31.9% among
women. The proportion of current drinkers of alcoholic beverages
was 46.9% for men and 5.4% for women, and the proportion of
current smokers was 51.6% for men and 9.6% for women. Regarding
the longest period occupational classification, the proportion of
participants engaged in clerical work was 11.7% among men and
9.6% among women, and the proportion of those unemployed was
2.8% among men and 19.7% among women.
Table 4 shows the follow-up results, Table 5 lists major types of
incident cancers, and Table 6 lists major causes of death by gender.
There were 20,240 total deaths (20.1%; 11,156 men and 9084
women), and 20,281 move-outs (20.2%; 9145 men and 11,136
women) (Table 4). The SIR of all cancers was 0.96 among men andTotal
54 55e59 60e64 65e69 70e74 75e79 80e84 85
5 6804 5018 4067 3410 2153 973 384 46,421
891 841 802 712 414 159 36 5106
13.1 16.8 19.7 20.9 19.2 16.3 9.4 11.0
1268 1407 1790 2054 1642 850 359 11,156
18.6 28.0 44.0 60.2 76.3 87.4 93.5 24.0
642 615 641 626 375 140 35 3902
9.4 12.3 15.8 18.4 17.4 14.4 9.1 8.4
8 1151 735 558 421 226 80 16 9145
16.9 14.6 13.7 12.3 10.5 8.2 4.2 19.7
45 71,783 50,831 37,773 28,223 14,550 5175 1666 464,664
12.4 16.5 21.2 25.2 28.5 30.7 21.6 11.0
28 83,102 59,579 44,107 32,193 16,278 5500 1714 527,940
15.3 23.6 40.6 63.8 100.9 154.5 209.4 21.1
7.7 10.3 14.5 19.4 23.0 25.5 20.4 7.4
7 7814 6604 5196 4261 2722 1471 740 54,189
483 513 539 478 296 121 37 3373
6.2 7.8 10.4 11.2 10.9 8.2 5.0 6.2
662 946 1365 1712 1648 1157 666 9084
8.5 14.3 26.3 40.2 60.5 78.7 90.0 16.8
286 325 410 404 278 115 34 2331
3.7 4.9 7.9 9.5 10.2 7.8 4.6 4.3
3 1483 1233 1012 758 440 166 58 11,136
19.0 18.7 19.5 17.8 16.2 11.3 7.8 20.6
90 85,763 71,427 53,084 40,224 22,468 9322 3172 567,271
5.6 7.2 10.2 11.9 13.2 13.0 11.7 5.9
,287 100,096 83,052 60,982 46,008 24,740 9927 3272 648,601
6.6 11.4 22.4 37.2 66.6 116.6 203.5 14.0
2.9 3.9 6.7 8.8 11.2 11.6 10.4 3.6
Table 5
Distribution of number of cancer incidence by site, gender, and age at baseline during 15-year follow-up.
ICD10 ICD9 Age at baseline, years Total %
40e44 45e49 50e54 55e59 60e64 65e69 70e74 75e79 80e84 85
Men
C00-C97 140e208.9 all cancer 215 371 665 891 841 802 712 414 159 36 5106 100.0
C15 150e150.9 Esophagus 14 20 25 43 35 29 29 8 4 0 207 4.1
C16 151e151.9 Stomach 52 94 180 235 224 191 187 95 34 10 1302 25.5
C18 153e153.9 Colon 26 40 78 74 75 75 52 37 19 1 477 9.3
C19-20 154e154.9 Rectum 18 28 29 44 46 33 23 21 3 1 246 4.8
C22 155e155.9 Liver and intrahepatic bile ducts 24 58 117 137 82 83 57 33 15 2 608 11.9
C23 156 Gall bladder 0 2 3 3 2 3 4 2 0 0 19 0.4
C24 156.1e156.9 Other and unspecified parts of biliary tract 4 4 11 9 11 20 15 8 4 2 88 1.7
C25 157e157.9 Pancreas 10 10 19 34 37 33 29 21 8 2 203 4.0
C33-34 162e162.9 Lung 24 38 79 120 160 174 160 85 25 8 873 17.1
C61 185e185.9 Prostate 1 7 10 39 31 41 35 25 15 2 206 4.0
C64 189e189.1 Kidney 3 10 8 21 14 11 8 7 0 0 82 1.6
C65-67 189.2e189.4 Urothelial tract 2 9 4 11 9 13 11 3 2 0 64 1.3
C82-85 202e202.9 Non-Hodgkin's 3 5 10 10 12 7 8 5 2 3 65 1.3
200e200.9
C90 203e203.8 Multiple myeloma 1 0 5 3 8 3 0 3 1 0 24 0.5
C92 205e205.9 Myeloid leukemia 4 3 7 6 5 7 3 3 1 2 41 0.8
Women
C00-C97 140e208.9 all cancer 229 291 386 483 513 539 478 296 121 37 3373 100.0
C15 150e150.9 Esophagus 0 1 1 4 4 5 5 5 0 0 25 0.7
C16 151e151.9 Stomach 32 49 59 83 104 103 96 63 35 6 630 18.7
C18 153e153.9 Colon 10 35 44 54 53 67 59 41 12 6 381 11.3
C19-20 154e154.9 Rectum 15 15 24 25 29 28 27 11 10 2 186 5.5
C22 155e155.9 Liver and intrahepatic bile ducts 5 14 22 31 38 43 29 11 8 2 203 6.0
C23 156 Gall bladder 0 3 3 3 5 5 4 6 0 0 29 0.9
C24 156.1e156.9 Other and unspecified parts of biliary tract 2 3 5 8 12 21 16 13 5 2 87 2.6
C25 157e157.9 Pancreas 3 6 9 26 25 35 28 19 5 1 157 4.7
C33-34 162e162.9 Lung 16 8 26 42 52 56 60 34 10 5 309 9.2
C50 174e175.9 Breast 72 74 71 73 58 42 30 13 6 0 439 13.0
C53 180e180.9 Cervi uteri 16 17 8 22 15 14 17 8 1 0 118 3.5
C54 182e182.9 Corpus uteri 9 13 22 15 7 8 4 0 0 0 78 2.3
C55 184e184.9 Uterus, part unspecified 0 0 1 1 2 3 1 1 2 0 11 0.3
C56 183e183.9 Ovary 15 13 18 12 8 10 12 7 4 0 99 2.9
C64 189e189.1 Kidney 2 1 4 3 2 2 5 1 3 0 23 0.7
C65-67 189.2e189.4 Urothelial tract 0 0 4 3 5 7 3 3 0 1 26 0.8
C82-85 200e200.9 Non-Hodgkin's 2 3 4 10 7 6 6 5 4 1 48 1.4
202e202.9
C90 203e203.8 Multiple myeloma 0 0 3 4 4 4 6 3 1 1 26 0.8
C92 205e205.9 Myeloid leukemia 4 5 3 4 3 6 1 2 0 0 28 0.8
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women, and the SMR of all cancers was 1.02 among men and 0.97
among women. Stomach cancer was the most frequent cancer
among men (25.5%) and women (18.7%), followed by lung cancer
among men (17.1%) and breast cancer among women (13.0%)
(Table 5). The leading cause of death was cancer among men
(35.0%) and cardiovascular disease among women (41.0%), and the
second-leading cause of death was cardiovascular disease among
men (33.0%) and cancer among women (25.7%) (Table 6). Among
those who died of cancer, the first-, second-, and third-leading
causes of death were cancer of the lung (21.9%), stomach (21.2%),
and liver (14.4%) among men, and cancer of the stomach (18.7%),
colon/rectum (13.2%), and lung (11.8%) among women.
Discussion
The Three-Prefecture Cohort Study, which had approximately
100,000 participants with consecutive follow-up for up to 15 years
and a 90% response rate to the baseline questionnaire survey
regarding participants' lifestyles, was one of the largest represen-
tative prospective, population-based cohort studies in Japan. The
study areas were selected because they contained national air
monitoring stations and the community-based cancer registry was
conducted actively; this large-scale observation enabled us to
determine not only all-cause mortality but also cancer incidenceamong community residents. The association of air pollution and
lung cancer mortality was reported previously.6 This report briefly
describes the characteristics (e.g., smoking status, alcohol drinking
status, and type of occupation) and endpoints among study par-
ticipants by gender.
This study had several strengths. First, more than 100,000 par-
ticipants answered a baseline questionnaire survey, and the
response rate was approximately 90%. This response rate was
similar to those of the JACC Study, which was launched in the mid-
1980s,1 and the JPHC Study, which was launched in the 1990s.2
Many cohort studies in Japan have focused on residents in rural
areas in order to conduct long-term follow-up.1,2 However, since
this study included both urban and rural areas, findings from this
cohort may help to evaluate the relationship between lifestyles and
various diseases, irrespective of area. This study population was
similar to the general population in cancer andmortality risks, with
SIR and SMR close to 1.0.11,12 Considering the large sample size, the
high questionnaire response rate, and adequate regional balance,
we consider that the association between participants' lifestyles
and endpoints measured in this study is generalizable to the whole
population of Japan. Second, in contrast to other large-scale cohorts
in Japan, the collection of detailed information on participants'
occupation, such as the longest period of employment, is another
strength of this study, and we will address the association between
occupation and incidence and mortality of non-communicable
Table 6
Distribution of number of deaths by cause, gender, and age at baseline during 15-year follow-up.
ICD10 ICD9 Age at baseline, years Total % %
40e44 45e49 50e54 55e59 60e64 65e69 70e74 75e79 80e84 85
Men
All causes 320 506 960 1268 1407 1790 2054 1642 850 359 11,156 100.0
A00-B99 1e139.8 Certain infectious and parasitic diseases 22 11 38 40 31 46 35 28 10 6 267 2.4
C00-C97 140e208.9 all cancer 135 230 463 642 615 641 626 375 140 35 3902 35.0 100.0
C15 150e150.9 Esophagus 15 13 22 41 32 27 26 9 7 0 192 4.9
C16 151e151.9 Stomach 28 39 104 126 120 137 151 84 29 11 829 21.2
C18 153e153.9 Colon 10 17 38 40 41 47 33 30 13 1 270 6.9
C19-20 154e154.9 Rectum 10 10 20 25 27 19 19 19 4 1 154 3.9
C22 155e155.9 Liver and intrahepatic bile ducts 16 52 107 127 80 76 60 29 14 2 563 14.4
C23 156 Gall bladder 0 4 4 4 10 9 6 4 0 1 42 1.1
C24 156.1e156.9 Other and unspecified parts of biliary tract 3 6 11 8 13 21 14 12 5 2 95 2.4
C25 157e157.9 Pancreas 9 14 21 39 41 36 33 23 6 2 224 5.7
C33-34 162e162.9 Lung 22 36 66 123 152 165 171 89 24 8 856 21.9
C61 185e185.9 Prostate 0 4 7 11 20 27 24 16 13 1 123 3.2
C64 189e189.1 Kidney 0 3 3 6 8 8 6 3 0 0 37 0.9
C65-67 189.2e189.4 Urothelial tract 0 0 1 4 2 3 3 1 0 0 14 0.4
C82-85 200e200.9 Non-Hodgkin's 3 2 9 12 11 10 13 8 2 2 72 1.8
202e202.9
C90 203e203.8 Multiple myeloma 1 1 3 2 5 3 2 3 0 0 21 0.5
C92 205e205.9 Myeloid leukemia 3 3 6 5 8 6 4 2 1 2 40 1.0
E00-E89 240e279.9 Endocrine, nutritional and
metabolic diseases
0 6 9 14 20 29 19 26 17 3 143 1.3
G00-G99 330e359.9 Diseases of the nervous system 1 5 6 9 12 18 10 8 3 0 72 0.6
I00-I99 390e459.9 Diseases of the circulatory system 76 121 242 304 407 578 772 644 364 173 3681 33.0
I20-I25 410e414.9 Ischemic heart disease 16 33 62 74 116 142 176 115 60 16 810
I48 427.3 Atrial fibrillation and flutter 0 0 3 2 1 6 7 6 4 2 31
I50 428e428.9 Heart failure 23 32 48 53 74 107 182 181 94 50 844
I60-69 430e438.9 Cerebrovascular disease 26 42 87 130 143 216 308 270 166 88 1476
I71 441e441.9 Aortic aneurysm and dissection 2 2 5 8 15 21 13 8 5 2 81
J00-J99 460e519.9 Diseases of the respiratory system 4 14 41 76 134 255 351 299 161 59 1394 12.5
J10-J18 480e487.9 Influenza 1 8 15 46 68 139 228 198 113 40 856
J43 492 Emphysema 0 0 5 5 5 22 19 14 4 5 79
K00-K93 520e579.9 Diseases of the digestive system 21 39 63 61 59 69 62 59 27 6 466 4.2
K74 571.5e571.6 Fibrosis and cirrhosis of liver 7 14 38 26 22 17 12 10 6 0 152
N00-N99 580e629.9 Diseases of the genitourinary system 4 7 12 29 36 37 57 53 25 8 268 2.4
N17-N19 584e586 Acute kidney failure and chronic
kidney disease
3 7 11 21 32 28 48 43 17 2 212
R00-R99 780e799.9 Symptoms, signs, and abnormal clinical and
laboratory findings, not elsewhere classified
7 3 5 15 17 33 51 80 67 56 334 3.0
R54 797 Age-related physical debility 1 0 0 1 1 11 15 57 52 55 193
S00-T88 800e999.9 External causes 42 56 60 57 53 43 41 35 21 5 413 3.7
Others 8 14 21 21 23 41 30 35 15 8 216 1.9
Women
All causes 181 301 446 662 946 1365 1712 1648 1157 666 9084 100.0
A00-B99 1e139.8 Certain infectious and parasitic diseases 6 7 21 24 36 31 38 33 21 4 221 2.4
C00-C97 140e208.9 all cancer 98 170 211 286 325 410 404 278 115 34 2331 25.7 100.0
C15 150e150.9 Esophagus 0 0 2 6 2 4 8 5 3 0 30 1.3
C16 151e151.9 Stomach 15 29 35 49 51 74 80 65 31 7 436 18.7
C18 153e153.9 Colon 5 16 22 27 25 30 46 33 10 5 219 9.4
C19-20 154e154.9 Rectum 3 10 13 16 13 19 16 10 9 2 111 4.8
C22 155e155.9 Liver and intrahepatic bile ducts 4 14 14 26 40 38 30 11 8 2 187 8.0
C23 156 Gall bladder 1 2 7 9 8 19 15 9 1 0 71 3.0
C24 156.1e156.9 Other and unspecified parts of biliary tract 3 6 8 7 13 21 14 16 7 2 97 4.2
C25 157e157.9 Pancreas 5 6 12 32 25 40 30 18 6 2 176 7.6
C33-34 162e162.9 Lung 11 12 17 36 38 55 57 33 11 5 275 11.8
C50 174e175.9 Breast 23 29 22 16 22 16 11 8 3 0 150 6.4
C53 180e180.9 Cervi uteri 5 4 1 4 7 8 5 4 0 0 38 1.6
C54 182e182.9 Corpus uteri 1 4 4 3 0 3 7 0 0 0 22 0.9
C55 184e184.9 Uterus, part unspecified 0 0 0 1 2 1 1 0 2 0 7 0.3
C56 183e183.9 Ovary 8 9 15 10 8 9 11 6 4 0 80 3.4
C64 189e189.1 Kidney 1 0 0 3 0 1 7 1 3 0 16 0.7
C65-67 189.2e189.4 Urothelial tract 0 0 2 1 4 1 2 0 0 0 10 0.4
C82-85 200e200.9 Non-Hodgkin's 1 2 4 8 9 9 3 6 4 1 47 2.0
202e202.9
C90 203e203.8 Multiple myeloma 0 1 3 4 4 5 8 4 1 0 30 1.3
C92 205e205.9 Myeloid leukemia 2 5 3 4 4 6 1 2 0 0 27 1.2
E00-E89 240e279.9 Endocrine, nutritional and
metabolic diseases
2 4 5 12 18 20 37 29 15 3 145 1.6
G00-G99 330e359.9 Diseases of the nervous system 3 2 8 4 11 13 9 12 4 0 66 0.7
I00-I99 390e459.9 Diseases of the circulatory system 33 65 112 171 322 543 753 780 600 343 3722 41.0
I20-I25 410e414.9 Ischemic heart disease 4 9 24 39 73 127 134 123 89 32 654
I48 427.3 Atrial fibrillation and flutter 0 0 0 2 0 3 7 8 2 1 23
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Table 6 (continued )
ICD10 ICD9 Age at baseline, years Total % %
40e44 45e49 50e54 55e59 60e64 65e69 70e74 75e79 80e84 85
I50 428e428.9 Heart failure 9 8 20 28 71 124 164 218 173 118 933
I60-69 430e438.9 Cerebrovascular disease 12 33 50 81 130 218 335 337 251 150 1597
I71 441e441.9 Aortic aneurysm and dissection 1 1 0 1 5 8 12 8 2 0 38
J00-J99 460e519.9 Diseases of the respiratory system 7 12 20 47 81 111 197 221 138 75 909 10.0
J10-J18 480e487.9 Influenza 1 4 8 25 44 72 133 149 98 67 601
J43 492 Emphysema 0 0 0 1 2 1 1 4 3 2 14
K00-K93 520e579.9 Diseases of the digestive system 9 9 24 39 38 62 68 68 54 26 397 4.4
K74 571.5e571.6 Fibrosis and cirrhosis of liver 5 5 10 18 17 22 22 10 2 0 111
N00-N99 580e629.9 Diseases of the genitourinary system 3 3 9 19 23 45 65 52 43 17 279 3.1
N17-N19 584e586 Acute kidney failure and chronic
kidney disease
3 3 8 17 18 33 50 38 29 16 215
R00-R99 780e799.9 Symptoms, signs, and abnormal clinical and
laboratory findings, not elsewhere classified
2 3 2 11 11 33 51 109 119 141 482 5.3
R54 797 Age-related physical debility 0 0 0 0 2 16 28 87 112 130 375
S00-T88 800e999.9 External causes 11 18 15 31 50 52 46 26 21 11 281 3.1
Others 7 8 19 18 31 45 44 40 27 12 251 2.8
J. Sado et al. / Journal of Epidemiology 27 (2017) 193e199 199diseases in the future using this cohort data. Third, the use of
community-based cancer incidence data from a cohort of 100,000
participants was also a strength of this study, because there are few
available analyses of cancer incidence data from large-scale cohort
studies in Japan. Fourth, this cohort can be pooled with other large-
scale cohorts in Japan (e.g., the JACC Study,1 the JPHC Study,2 or the
Ohsaki Cohort13) and serve to provide new findings from Japan.
This study has several limitations. First, this registry was
launched in the 1980s and its follow-up of participants was
completed in 2000. The associations between participants' lifestyles
and endpoints might differ from those since 2000, because lifestyles
diversify with the times. Second, in cohort studies, non-
questionnaire responders had more unfavorable lifestyles than
responders2,14e16 and were less likely to join the health check-ups.2
However, the overall response rate in this cohort was almost 90%,
and we consider that the impact of differences between responders
in cities and those in towns would be small. Furthermore, the
numbers of delivered questionnaires in Sendai City and Osaka City
were fewer than those in other cities/towns, because residents' local
organizations did not cover the entire community and could not
deliver questionnaires in the whole region. Therefore, the repre-
sentativeness would be weaker in these areas than in other areas.
Third, we could not evaluate the energy intake or nutrient con-
sumption of participants because the Three-Prefecture Cohort Study
used a food frequency questionnaire with a small number of items.
Conclusions
The Three-Prefecture Cohort Study was conducted from the
1980s to 2000 and is one of the largest representative prospective
population-based cohort studies in Japan. This study enabled us to
reveal the association of multiphasic lifestyle factors with cancer
incidence and mortality in a single cohort. It will also allow us to
conduct a pooled analysis in combination with other large-scale
cohorts, which will be of considerable help in gaining insights
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